Transcept Pharmaceuticals (TSPT +6.8%) gets some follow-through off yesterday's +10% run, moving higher again today off the news that its sleep drug Intermezzo dodged an FDA bullet requiring a number of other sleep aids to reduce their dosage due to the risk of impaired cognitive function issues. The drug is the company's first FDA approved product.
Transcept Pharmaceuticals (TSPT +6.8%) gets some follow-through off yesterday's +10% run, moving...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs